炎症反应与缺血性卒中

doi:10.3969/j.issn.1673-5765.2020.01.018

摘要/Abstract

摘要：

炎症反应是缺血性卒中后病理生理的核心内容，其过程涉及免疫和炎症细胞，不同途径和来源的被激活的炎症因子共同参与。早期小胶质细胞、中性粒细胞被激活，随之淋巴细胞的聚集和浸润也增加了对脑细胞的损伤；但也有研究发现，在特定刺激下，中性粒细胞可以从促炎表型向抗炎表型转变，进而保护脑细胞；淋巴细胞中部分T细胞亚型可以抑制促炎因子的表达、调节淋巴细胞的活性，从而起到脑保护作用。另外，在缺血性卒中后，除脑内局部的炎症反应外，外周循环的炎性反应和免疫抑制也参与其病理机制。免疫调节有望成为未来缺血性卒中治疗的靶点。

关键词: 缺血性卒中; 炎症细胞; 炎症反应

Abstract:

Inflammatory response is one of the important pathophysiology reactions after ischemic stroke, the process of which involves the joint participation of immune and inflammatory cells, activated inflammatory factors from different pathways and sources. Early microglia and neutrophils are activated, and the aggregation and infiltration of lymphocytes can increase the damage to brain tissue. Studies have found that under specific stimuli, neutrophils can change from a pro-inflammatory phenotype to an anti-inflammatory phenotype, which can protect brain cells; some T cell subtypes of lymphocytes can inhibit the expression of pro-inflammatory factors and regulate lymphocytes activity, which plays a protective role in the brain. After ischemic stroke onset, in addition to the local inflammatory response in the brain, the inflammatory response and immunosuppression from the peripheral circulation also participate in the pathophysiological reactions. Immune regulation may become a target for the treatment of ischemic stroke in the future.

Key words: Ischemic stroke; Inflammatory cell; Inflammatory response

邱晓雪，李世文，于鹭，武一平，林杰. 炎症反应与缺血性卒中[J]. 中国卒中杂志, 2020, 15(01): 108-114.

QIU Xiao-Xue, LI Shi-Wen, Yu Lu, Wu Yi-Ping, Lin Jie. Inflammatory Response and Ischemic Stroke[J]. Chinese Journal of Stroke, 2020, 15(01): 108-114.

参考文献

[1] JICKLING G C，LIU D，ANDER B P，et al.

Targeting neutrophil in ischemic stroke：translational

insights from experimental studies[J]. J Cereb Blood

Flow Metab，2015，35（6）：888-901.

[2] KOLACZKOWSKA E，KUBES P. Neutrophil

recruitment and function in health and

inflammation[J]. Nat Rev Immuno，2013，13（3）：

159-175.

[3] TSAI N W，CHANG W N，SHAW C F，et al.

Leucocyte apoptosis in patients with acute ischaemic

stroke[J]. Clin Exp Pharmacol Physiol，2010，37（9）：

884-888.

[4] SUMMERS C，RANKIN S M，CONDLIFFE A M，

et al. Neutrophil kinetics in health and disease[J].

Trends Immunol，2010，31（8）：318-324.

[5] BENAKIS C，GARCIA-BONILLA L，IADECOLA

C，et al. The role of microglia and myeloid immune

cells in acute cerebral ischemia[J/OL]. Front Cell

Neurosci，2015，8：461. https：//doi.org/10.3389/

fncel.2014.00461.

[6] 贾玉龙，李力仙，刘龙，等. 亚低温对脑缺血再灌注

损伤的治疗作用及其机制的初探[J]. 国际免疫学杂

志，2016，39（2）：111-115.

[7] WANG Y，JIN H，WANG W，et al. Myosin1fmediated

neutrophil migration contributes to acute

neuroinflammation and brain injury after stroke in

mice[J]. J Neuroinflammation，2019，16（1）：77.

[8] KIM J Y，PARK J，CHANG J Y，et al. Inflammation

after ischemic stroke：the role of leukocytes and glial

cells[J]. Exp Neurobiol，2016，25（5）：241-251.

[9] FURLAN J C，VERGOUWEN M D，FANG J，et al.

White blood cell count is an independent predictor

of outcomes after acute ischaemic stroke[J]. Eur J

Neurol，2014，21（2）：215-222.

[10] PEREZ-DE-PUIG I，MIRO-MUR F，FERRERFERRER

M，et al. Neutrophil recruitment to the

brain in mouse and human ischemic stroke[J]. Acta

Neuropathol，2015，129（2）：239-257.

[11] HERZ J，SABELLEK P，LANE T E，et al. Role of

neutrophil in exacerbation of brain injury after focal

cerebral ischemia in hyperlipidemic mice[J]. Stroke，

2015，46（10）：2916-2925.

[12] GAUTIER S，OUK T，TAGZIRT M，et al. Impact

of the neutrophil response to granulocyte colonystimulating

factor on the risk of hemorrhage when

used in combination with tissue plasminogen

activator during the acute phase of experimental

stroke[J]. J Neuroin Flammation，2014，11（96）：

1-10.

[13] BRAIT V H，ARUMUGAM T V，DRUMMOND G

R，et al. Importance of T lymphocytes in brain injury，

immunodeficiency，and recovery after cerebral

ischemia[J]. J Cereb Blood Flow Metab，2012，32

（4）：598-611.

[14] YILMAZ G，ARUMUGAM T V，STOKES K Y，

et al. Role of T lymphocytes and interferon-γ in

ischemic stroke[J]. Circulation，2006，113（17）：

2105-2112.

[15] KLEINSCHNITZ C，SCHWAB N，KRAFT P，et

al. Early detrimental T-cell effects in experimental

cerebral ischemia are neither related to adaptive

immunity nor thrombus formation[J]. Blood，2010，

115（18）：3835-3842.

[16] ZHANG Y，WEI L，DU Y，et al. Association

between programed cell death-1 and CD4（+）T cell

alterations in different phases of ischemic stroke

patients[J]. Front Cell Neurosci，2018，12（1）：170-

181.

[17] SHICHITA T，SUGIYAMA Y，OOBOSHI H，et al.

Pivotal role of cerebral interleukin-17-producing γδT

cells in the delayed phase of ischemic brain injury[J].Nat Med，2009，15（8）：946-950.

[18] REN X，AKIYOSHI K，DZIENNIS S，et al.

Regulatory B cells limit CNS inflammation and

neurologic deficits in murine experimental stroke[J].

J Neurosci，2011，31（23）：8556-8563.

[19] 陈瑞清，谭盛，陈健，等. 大鼠急性脑缺血后

CD4+CD25+调节性T细胞、Foxp3表达及其意义[J].

南方医科大学学报，2012，32（5）：659-664.

[20] 周楷. Treg细胞通过LI-10/GSK3β/PTEN信号调节小

胶质/巨噬细胞极化减轻脑出血炎症损伤大[D]. 重庆：

第三军医大学，2016.

[21] MAO L，LI P，ZHU W，et al. Regulatory T cells

ameliorate tissue plasminogen activator‐induced

brain haemorrhage after stroke[J]. Brain，2017，140

（7）：1914-1931.

[22] KIERDORF K，KATZMARSKI N，HAAS C A，et

al. Bone marrow cell recruitment to the brain in the

absence of irradiation or parabiosis bias[J/OL]. PLoS

One，2013，8（3）：e58544. https：//doi.org/10.1371/

journal.pone.0058544.

[23] KETTENMANN H，HANISCH U K，NODA M，et

al. Physiology of microglia[J]. Physiol Rev，2011，91

（2）：461-553.

[24] LADECOLA C，ANRATHER J. The immunology

of stroke：from mechanisms to translation[J]. Nat

Med，2011，17（7）：796-808.

[25] COTRINA M L，LOU N，TOME-GARCIA J，et

al. Direct comparison of microglial dynamics and

inflammatory profile in photothrombotic and arterial

occlusion evoked stroke[J]. Neuroscience，2017，343

（20）：481-494.

[26] DAVALOS D，GRUTZENDLER J，YANG G，et

al. ATP mediates rapid microglial response to local

brain injury in vivo[J]. Nat Neurosci，2005，8（6）：

752-758.

[27] PRINZ M，PRILLER J. Microglia and brain

macrophages in the molecular age：from origin to

neuropsychiatric disease[J]. Nat Rev Neurosci，2014，

15（5）：300-312.

[28] YANG Y，SALAYANDIA V M，THOMPSON J

F，et al. Attenuation of acute stroke injury in rat

brain by minocycline promotes blood‐brain barrier

remodeling and alternative microglia/macrophage

activation during recovery[J]. J Neuroinflammation，

2015，12（26）：1-15.

[29] 李秋萌，张文倩，谭赢. Treg细胞通过LI-10/STAT3诱

导小胶质细胞M2型极化减轻脑出血炎症损伤[J]. 第

三军医大学学报，2018，40（16）：1461-1468.

[30] BROWN G C，NEHER J J. Microglial phagocytosis

of live neurons[J]. Nat Rev Neurosci，2014，15（4）：

209-216.

[31] XIE L，SUN F，WANG J，et al. mTOR signaling

inhibition modelates macrophage/microgliamediated

neuro inflammation and secongary injury

via regulatory T cells after focal ischemia[J]. J

Immunol，2014，192（1）：6009-6019.

[32] YANG Y，ROSENBERG G A. Matrix

metalloproteinases as therapeutic targets for

stroke[J]. Brain Res，2015，1623（14）：30-38.

[33] DANG B，DUAN X，WANG Z，et al. A the rapeutic

target of cerebral hemorrhagic stroke：matrix

metalloproteinase- 9[J]. Current Drug Targets，2017，

18（12）：1358-1366.

[34] ABDELNASEER M M，ELFAUOMY N M，

ESMAIL E H，et al. Matrix metalloproteinase-9

and recovery of acute ischemic stroke[J]. J Stroke

Cerebrovasc Dis，2017，26（4）：733-740.

[35] KAWABORI M，YENARI M A. Inflammatory

responses in brain ischemia[J]. Curr Med Chem，

2015，22（10）：1258-1277.

[36] LUDEWING P，SEDLACIK J，GELDERBLOM

M，et al. Carcinoembryonic antigen-related cell

adhesion molecule 1 inhibits MMP-9-mediated

blood-brain-barrier breakdown in a mouse model for

ischemic stroke[J]. Circ Res，2013，113（8）：1013-

1022.

[37] DINARELLO C A. A clinical perspective of IL-1β

as the gatekeeper of inflammation[J]. Eur J Immunol，

2011，41（5）：1203-1217.

[38] LUHESHI N M，KOVACS K J，LOPEZ-CASTEJON

G，et al. Interleukin-1α expression precedes IL-1β

after ischemic brain injury and is localised to areas

of focal neuronal loss and penumbral tissues[J]. J

Neuroinflamm，2011，8（29）：186-191.

[39] SMITH C J，HULME S，VAIL A，et al. SCILSTROKE（

Subcutaneous Interleukin-1 Receptor

Antagonist in Ischemic storke）：a randomized

controlled phase 2 trial[J]. Storke，2018，49（5）：

1210-1216.

[40] ZHAO B，ZOU C J，ZHOU P. Delayed

administration IL-1β neutralizing antibody improves

cognitive function after transient global ischemia in

rats[J]. Behav Brain Res，2016，303（1）：53-60.

[41] SAMY Z A，AI-ABDULLAH L，TURCANI M，et

al. Rat astrocytes during anoxia：secretome profile of

cytokines ang chemokines[J/OL]. Brain Behav，2018，

8（7）：e01013. https：//doi.org/10.1002/brb3.1013.

[42] MAURO A G，MEZZAROMA E，TORRADO

J，et al. Reduction of myocardial ischeat astrocytes

during anoxia：secretome profile of cytokines ang

chemokines[J]. J Cardiovasc Pharmacol，2017，69

（3）：156-160.

[43] MURRAY K N，PARRY-JONES A R，ALLAN S

M. Interleukin-1 and acute brain injury[J]. Front Cell

Neurosci，2015，9（18）：1-17.

[44] SOBOWALE O A，PARRY-JONES A R，SMITH

C J，et al. Interleukin-1 in stroke：from bench to

bedside[J]. Stroke，2016，47（8）：2160-2167.

[45] RIDKER P M，EVERETT B M，THUREN T，et

al. Antiinflammatory therapy with canakinumab for

atherosclerotic disease[J]. N Engl J Med，2017，377

（12）：1119-1131.

[46] WAISMAN A，HAUPTMANN J，REGEN T. The

role of IL-17 in CNS diseases[J]. Acta Neuropathol，

2015，129（5）：625-637.

[47] GELDERBLOM M，WEYMAR A，

BERNREUTHER C，et al. Neutralization of the IL-

17 axis diminishes neutrophil invasion and protects

from ischemic stroke[J]. Blood，2012，120（18）：

3793-3802.

[48] ELTZSCHIG H K，CARMELIET P. Hypoxia and

inflammation[J]. N Engl J Med，2011，364（7）：656-

665.

[49] KIGERL K A，DE RIVERO VACCARI J P，

DIETRICH W D，et al. Pattern recognition receptors

and central nervous system repair[J]. Exp Neurol，

2014，258（8）：5-16.

[50] JIN R，XIAO A Y，CHEN R，et al. Inhibition of

CD147（cluster of differentiation 147）ameliorates

acute ischemic stroke in mice by reducing

thromboinflammation[J]. Stroke，2017，48（12）：

3356-3365.

[51] DENES A，MCCOLL B W，LEOW-DYKE S F，et

al. Experimental stroke-induced changes in the bone

marrow reveal complex regulation of leukocyte

responses[J]. J Cereb Blood Flow Metab，2011，31

（4）：1036-1050.

[52] GVANGILDER R L，DAVIDOV D M，STINEHART

K R，et al. C-reactive protein and long-term ischemic

stroke prognosis[J]. J Clin Neurosci，2014，21（4）：

547-553.

[53] YAN F L，ZHANG J H. Role of the sympathetic

nervous system and spleen in experimental strokeinduced

immunodepression[J]. Med Sci Monit，2014，

20（1）：2489-2496.

[54] WESTENDORP W F，VERMEIJ J D，ZOCK E，et

al. PASS investigators. The Preventive Antibiotics

in Stroke Study（PASS）：a pragmatic randomised

open-ladel masked endpoint clinical trial[J]. Lancet，

2015，385（9977）：1519-1526.

[55] SYKORA M，SIARNIK P，DIEDLER J. VISTA

Acute Collaborators. β-blockers，pneumonia，and

outcome after ischemic stroke：evidence form

Virtual International Stroke Trials Archive[J]. storke，

2015，46（5）：1269-1274.